- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in COVID 19 Vaccine
Tomar Announces India's First Covid-19 Vaccine Anocovax For Animals
The vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant. It is safe for dogs, lions, leopards, mice and rabbits
Read More
Ensure Last-mile Vaccine Coverage Of Beneficiaries: Delhi Govt To Districts
The government has made arrangements for free vaccination of people in the age group of 18 to 59 years, in addition to providing free precaution doses to those above 60, health care and frontline workers
Read More
India’s Cumulative COVID-19 Vaccination Coverage Exceeds 185.04 Cr
India’s active caseload declined to 11,871 active cases which constitute 0.03 per cent of the country's total positive cases, said the ministry
Read More
India’s Cumulative COVID-19 Vaccination Coverage Exceeds 184.52 Cr
India’s recovery rate stands at 98.76 per cent. About 1,404 patients have recovered in the last 24 hours and the cumulative tally of recovered patients is now at 4,24,92,326
Read More
India’s Cumulative COVID-19 Vaccination Coverage Exceeds 178.55 Cr: Centre
The weekly positivity rate in the country currently stands at 0.84 per cent and the Daily Positivity rate is at 0.63 per cent
Read More
Foreign COVID-19 Vaccine Firms Can Do Business, But On India's Terms: Mandaviya
He was speaking at the launch of a book titled 'A Nation To Protect - Leading India Through The Covid Crisis' and authored by Priyam Gandhi Mody
Read More
Over 20 Mn Adolescents In 15-18 Age Group Fully Vaccinated
According to the Registrar General of India (RGI), the estimated population of beneficiaries in the age group of 15-18 years is 7.4 crores for 2021-22
Read More
India Reports 67,084 New Cases, Vaccination Coverage Exceeds 171.28 Cr
More than 169.19 crore (1,69,19,79,990) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through the direct state procurement category, the ministry informed.
Read More
India’s Cumulative COVID-19 Vaccination Coverage Exceeds 168 Cr Mark: Centre
The last 24 hours saw a total of 16,03,856 tests being conducted. India has so far conducted over 73.79 cr (73,79,32,233) cumulative tests, according to the ministry.
Read MoreOver 34 lakh Eligible Adolescents Given Second Dose Of COVID-19 Vaccine: Govt
With the administration of more than 55 lakh vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 168.47 crore as per provisional reports till 7 am.
Read More
Trying To Bring Sputnik M Vaccine For Adolescents To India: Dr Reddy's
On Molnupiravir, the official said in this current wave Omicron is the dominant variant and it has seen relatively lower hospitalisations.
Read More
Annual COVID Vax Preferred To Frequent Boosters: Pfizer CEO
"This will not be a good scenario. What I'm hoping (is) that we will have a vaccine that you will have to do once a year," Bourla said.
Read More
India's Gennova Working On Omicron-specific COVID-19 Vaccine
The source, who did not want to be named as the information was private, said the product might need a small trial in India before it could be rolled out as a booster or standalone vaccine.
Read More
India's COVID-19 Cases Multiply, Vulnerable Groups Given Vaccine Boosters
India reported 179,723 new cases on Monday, most of them in the country's biggest cities - Delhi, Mumbai and Kolkata - where Omicron has overtaken Delta as the most prevalent strain of the virus.
Read More
Multivariant COVID Vaccine Booster Shows Promise, Early Data Suggests
The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies, similar to approved mRNA vaccines, but at up to a 10-fold lower dose in the first 10 individuals
Read More